Related Experiment Video
Updated: Aug 13, 2026
09:23
Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Towards grey-zone reliability in CA19-9 nanobiosensing: an AI-integrated molecular interface design-to-decision
Ziyi Shang1,2, Linya Shan1,2, Che Liu3
1Nano Research Laboratory, School of Pharmacy, Jinzhou Medical University, Jinzhou, China. danli@jzmu.edu.cn.
Chemical Communications (Cambridge, England)
|August 10, 2026
Summary
This review proposes a reliability-centered nanobiosensing framework for interpreting borderline CA19-9 levels. It integrates advanced techniques to improve diagnostic accuracy in the ambiguous "grey zone," reducing patient anxiety and overdiagnosis.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Clinical Diagnostics
Background:
- Mildly elevated CA19-9 levels create a diagnostic
- grey zone
- , leading to patient anxiety and overdiagnosis.
- Current nanobiosensing research often prioritizes low detection limits over clinical reliability in this ambiguous range.
Purpose of the Study:
- To advocate for a shift from sensitivity-only reporting to reliability-centered translational nanobiosensing for specific use cases.
- To propose an integrated
- grey-zone reliability metrology
- framework for improved interpretation of borderline biomarker levels.
Main Methods:
- Unifying antifouling interface engineering, high-affinity molecular recognition, signal amplification, and AI-assisted interpretation into a co-dependent system.
- Implementing interference-aware denoising, longitudinal trajectory modeling, and patient-specific baseline inference for signal qualification.
- Developing a design-to-decision logic for clinical interpretation of borderline biomarker signals.
Main Results:
- The proposed framework aims to qualify and contextualize borderline CA19-9 signals for clinical interpretation.
- It focuses on managing analytical uncertainty within an already measurable interval.
- The framework offers a transferable approach for other grey-zone biomarkers like cardiac troponins and circulating tumor DNA.
Conclusions:
- A reliability-centered nanobiosensing approach is crucial for addressing the challenges of diagnostic grey zones.
- The proposed metrology framework enhances decision reliability by integrating multiple technological components.
- This approach provides a cautious yet transferable framework for next-generation diagnostics, balancing sensitivity with clinical decision-making.
